Shorter versus longer duration of antibiotic therapy in patients with community-acquired pneumonia: a rapid review
Ghazipura M
Record ID 32014001054
English
Authors' objectives:
The aim of this rapid review is to determine the optimal duration for administering antibiotics to patients
presenting with community-acquired pneumonia (CAP).
Authors' recommendations:
On the basis of 1 SR evaluating the optimal duration for antibiotic therapy in patients presenting to the emergency department with signs of community-acquired pneumonia, the following conclusions were reached:
High quality evidence indicates that there is no significant difference in mortality for patients who received antibiotic therapy for >= 7 days compared to those who received antibiotic therapy for < 7 days.
There was no available evidence assessing the impact of the duration of antibiotic therapy on length of hospital stay.
Details
Project Status:
Completed
Year Published:
2013
URL for published report:
http://www.hqontario.ca/Portals/0/Documents/eds/rapid-reviews/pneumonia-duration-antibiotic-therapy-131120-en.pdf
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Anti-Bacterial Agents
- Pneumonia, Bacterial
Contact
Organisation Name:
Health Quality Ontario
Contact Address:
Evidence Development and Standards, Health Quality Ontario, 130 Bloor Street West, 10th floor, Toronto, Ontario Canada M5S 1N5
Contact Name:
EDSinfo@hqontario.ca
Contact Email:
OH-HQO_hta-reg@ontariohealth.ca
Copyright:
Health Quality Ontario
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.